Blog

Aug 30, 2024, 16:29

Julie Gralow: Dr. Debra Patt discusses newly released ASCO Guiding Principles for Responsible Use of AI

Julie Gralow, Chief Medical Officer,

“American Society of Clinical Oncology (ASCO) Board Member and Chair of ASCO’s AI Task Force, Dr. Debra Patt, discusses newly released ASCO Guiding Principles for Responsible Use of AI.”

Quote from Debra A. Patt, MD, PhD, MBA, FASCO

Additional info

Source: Julie Gralow/Linkedin

Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN)

American Society for Clinical Oncology (ASCO) artifical intelligence Artificial Intelligence in Oncology ASCO cancer Debra Patt Julie Gralow OncoDaily Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage